1. Home
  2. HOMB vs ALKS Comparison

HOMB vs ALKS Comparison

Compare HOMB & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home BancShares Inc.

HOMB

Home BancShares Inc.

HOLD

Current Price

$28.38

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$29.52

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOMB
ALKS
Founded
1998
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.8B
IPO Year
2006
1991

Fundamental Metrics

Financial Performance
Metric
HOMB
ALKS
Price
$28.38
$29.52
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$32.40
$42.85
AVG Volume (30 Days)
882.9K
2.5M
Earning Date
01-14-2026
10-28-2025
Dividend Yield
2.96%
N/A
EPS Growth
18.95
2.44
EPS
2.30
2.02
Revenue
$1,042,417,000.00
$1,521,338,000.00
Revenue This Year
$13.21
N/A
Revenue Next Year
$3.01
$24.22
P/E Ratio
$12.35
$14.67
Revenue Growth
7.75
1.08
52 Week Low
$24.22
$25.17
52 Week High
$31.57
$36.45

Technical Indicators

Market Signals
Indicator
HOMB
ALKS
Relative Strength Index (RSI) 57.72 48.29
Support Level $27.80 $28.96
Resistance Level $28.65 $30.10
Average True Range (ATR) 0.56 0.92
MACD 0.13 0.02
Stochastic Oscillator 89.10 68.21

Price Performance

Historical Comparison
HOMB
ALKS

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: